These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 11529855)

  • 1. Successful treatment with cyclosporin A for myelodysplastic syndrome with erythroid hypoplasia associated with T-cell receptor gene rearrangements.
    Shimamoto T; Iguchi T; Ando K; Katagiri T; Tauchi T; Ito Y; Yaguchi M; Miyazawa K; Kimura Y; Masuda M; Mizoguchi H; Ohyashiki K
    Br J Haematol; 2001 Aug; 114(2):358-61. PubMed ID: 11529855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppressive treatments for myelodysplastic syndromes.
    Shimamoto T; Ohyashiki K
    Leuk Lymphoma; 2003 Apr; 44(4):593-604. PubMed ID: 12769335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of myelodysplastic syndrome with erythroid hypoplasia associated with a familial translocation t(3;14)(p21.1;q24.1).
    Dinçol G; Oztürk S; Palanduz S; Tutkan G; Yildirim N; Ayer M; Güvenç S
    Am J Hematol; 2006 Nov; 81(11):883-7. PubMed ID: 16888788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A preliminary report on treatment of myelodysplastic syndrome with cyclosporin a and androgen].
    Wang JW; Ning F; Liu XD; Lou JX; Chen P; Liu B
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Dec; 12(6):855-7. PubMed ID: 15631678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myelodysplastic syndrome with erythroid hypoplasia is a new clinical entity responsive to cyclosporin A therapy.
    Shimamoto T; Ohyashiki K
    Leuk Lymphoma; 2002 Sep; 43(9):1895-6. PubMed ID: 12685853
    [No Abstract]   [Full Text] [Related]  

  • 6. [Successful immunosuppressive therapy for a patient with hypoplastic myelodysplastic syndrome].
    Takanashi M; Kadono Y; Tabata Y; Hibi S
    Rinsho Ketsueki; 1999 Oct; 40(10):1093-9. PubMed ID: 10565227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Myelodysplastic syndrome with der (1;7) transformed from aplastic anemia 42 years after onset].
    Kanemura N; Tsurumi H; Hara T; Yamada T; Moriwaki H
    Rinsho Ketsueki; 2005 May; 46(5):372-4. PubMed ID: 16444972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myelodysplastic syndrome with erythroid hypoplasia/aplasia: a case report and review of the literature.
    García-Suárez J; Pascual T; Muñoz MA; Herrero B; Pardo A
    Am J Hematol; 1998 Aug; 58(4):319-25. PubMed ID: 9692397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Successful treatment with cyclosporine for myelodysplastic syndrome with erythroid hypoplasia following rheumatoid arthritis].
    Tsuji T; Yamasaki H; Tsuda H
    Rinsho Ketsueki; 2010 Jun; 51(6):427-32. PubMed ID: 20622490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Application of cyclosporine A in myelodysplastic syndrome--review].
    Guan M
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Dec; 11(6):678-80. PubMed ID: 14706160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apoptotic cells and clonally expanded cytotoxic T cells in bone marrow trephines of patients with myelodysplastic syndrome.
    Pülhorn H; Herrmann M; Harms H; Jung A; Baumann I
    Histopathology; 2012 Aug; 61(2):200-11. PubMed ID: 22690734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hematologic response predictor factors in adults with myelodysplastic syndromes (SMD) treated with cyclosporin A (CSA)].
    Zamora-Pérez E; López-Karpovitch X
    Gac Med Mex; 2015; 151(3):345-53. PubMed ID: 26089271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful treatment with cyclosporin A of myelodysplastic syndrome with erythroid hypoplasia associated with t(6;8)(q15;q22).
    Takata S; Kojima K; Fujii N; Kaneda K; Yoshida C; Hashimoto D; Asakura S; Shinagawa K; Tanimoto M
    Cancer Genet Cytogenet; 2003 Jan; 140(2):167-9. PubMed ID: 12645657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cyclosporine A based therapy for myelodysplastic syndrome].
    Li ZL; Gong M; Xu SH; Huang FZ; Chen YR; Ma YG
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Oct; 13(5):867-70. PubMed ID: 16277860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficiency of cyclosporin A therapy in patients with myelodysplastic syndrome].
    Kokhno AV; Parovichnikova EN; Mikhaĭlova EA; Ustinova EN; Kaplanskaia IB; Dvirnyk VN; Ol'shanskaia IuV; Domracheva EV; Savchenko VG
    Ter Arkh; 2010; 82(8):48-53. PubMed ID: 20873246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of cyclosporine on hematopoietic and immune functions in patients with hypoplastic myelodysplasia: in vitro and in vivo studies.
    Selleri C; Maciejewski JP; Catalano L; Ricci P; Andretta C; Luciano L; Rotoli B
    Cancer; 2002 Nov; 95(9):1911-22. PubMed ID: 12404285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The detection of T-cell receptor gene rearrangement in myelodysplastic syndromes].
    Xu B; Yang Y; Xu X; Wang S; Zhou S; Meng F
    Zhonghua Nei Ke Za Zhi; 1999 Oct; 38(10):685-7. PubMed ID: 11798708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporin A for the treatment of pure red cell aplasia associated with myelodysplasia.
    Grigg AP; O'Flaherty E
    Leuk Lymphoma; 2001; 42(6):1339-42. PubMed ID: 11911417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunosuppressive therapy for hypoplastic myelodysplastic syndrome.
    Biesma DH; van den Tweel JG; Verdonck LF
    Cancer; 1997 Apr; 79(8):1548-51. PubMed ID: 9118037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term improvement of hematopoiesis following cyclosporine treatment in a patient with myelodysplastic syndrome.
    Berer A; Ohler L; Simonitsch I; Thalhammer R; Lechner K; Geissler K
    Wien Klin Wochenschr; 1999 Oct; 111(19):815-8. PubMed ID: 10568013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.